• Clinical Technology
  • Adult Immunization
  • Hepatology
  • Pediatric Immunization
  • Screening
  • Psychiatry
  • Allergy
  • Women's Health
  • Cardiology
  • Pediatrics
  • Dermatology
  • Endocrinology
  • Pain Management
  • Gastroenterology
  • Infectious Disease
  • Obesity Medicine
  • Rheumatology
  • Nephrology
  • Neurology
  • Pulmonology

Talking to Patients About Weight

Slideshow

Addressing weight issues with patients can be tricky, but these 8 tips can help make that awkward conversation a little easier. 

According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), ~70% of US adults are overweight. The associated health risks include diabetes, cardiovascular disease, kidney disease, and some cancers.Every physician knows the importance of addressing weight issues with their patients, yet providers often neglect to help patients with weight problems because they don’t know how to initiate the conversation. Patient Care® Online asked 2 physicians for suggestions on how to make that awkward conversation a little bit easier. Scroll through the slideshow below for their top tips.

Related Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Overweight and Obesity: One Expert's 3 Wishes for the Future of Patient Care
Donna H Ryan, MD Obesity Expert Highlights 2021 Research Success and Looks to 2022 and Beyond
"Obesity is a Medically Approachable Problem" and Other Lessons with Lee Kaplan, MD, PhD
Related Content
Novo Nordisk Files NDA for CagriSema, Novel GLP-1-amylin Combination for Chronic Weight Management / image credit ©JHVE/stock.adobe.com

Novo Nordisk Files NDA for CagriSema, Novel GLP-1-amylin Combination for Chronic Weight Management

Grace Halsey
December 18th 2025
Article

The phase 3 REDFINE program showed mean weight loss of 20% at 68 weeks, supporting the dual-mechanism approach that combines semaglutide with cagrilintide.

Weekly Dose Podcast: CRC Screening Uptake, GLP-1 Eligibility in Youth, Women’s Heart Health, and Ultraprocessed Food Risks

Weekly Dose Podcast: CRC Screening Uptake, GLP-1 Eligibility in Youth, Women’s Heart Health, and Ultraprocessed Food Risks

Sydney Jennings
August 28th 2025
Podcast

This week’s podcast episode covers CRC screening, GLP-1 eligibility in youth, women’s heart health, FIT outreach, and ultraprocessed food risks.

ADA Publishes 2026 Standards of Care With Updates to Sections on Technology, Obesity, Cardiometabolic Disease Management / image credit Rita R Kalyani, MD, MHS Courtesy of the American Diabetes Assocation

ADA Publishes 2026 Standards of Care With Updates to Sections on Technology, Obesity, Cardiometabolic Disease Management

Grace Halsey
December 9th 2025
Article

The 2026 annual updates to the Standards of Care in Diabetes include wider CGM use, guidance on dosing of antiobesity drugs, and glycemic management during cancer therapy.

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

Sydney Jennings
August 30th 2023
Podcast

Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.

Obesity Linked to Faster Alzheimer’s Disease Progression in Longitudinal Blood Biomarker Analysis / image credit Cyrus Raji, MD, PhD Courtesy of RSNA

Obesity Linked to Faster Alzheimer Disease Progression in Longitudinal Blood Biomarker Analysis

Grace Halsey
December 2nd 2025
Article

Biomarker trajectories over 5 years in study participants with AD show steeper rises in pTau217, NfL, and amyloid burden among those with obesity, highlighting risk factor relevance.

WHO Issues First Global Guidelines on GLP-1 Receptor Agonists for Obesity Treatment / image credit ©World Health Organization

WHO Issues First Guidelines on GLP-1 Receptor Agonists for Obesity Treatment

Grace Halsey
December 2nd 2025
Article

The landmark global policy recognizes obesity as chronic disease requiring lifelong care, warns of inequitable access and proposes 3-pillar strategy targeting prevention, screening, treatment.

© 2025 MJH Life Sciences

All rights reserved.